Colposcopy
Colposcopy has been studied in 13 papers since 2023: 11 observational studies in people, 1 review; 12 in the past year. The newest paper, Nov 12, 2026: “Risk-Based Triage of Women with Persistent HR-HPV Positivity at 12-Month Recall in Cervical Cancer Screening: A Multicenter Retrospective Evaluation of Cytology and Partial HPV Genotyping”.
3 new papers in 30 daysSee all 13 papers on colposcopy
At a glance
The findings reach people, from one lab or study. 1 lab in 2 countries.
“Sensitivity was 91·2% (95% CI 88·9-93·2) for CIN3+”
- 1 lab in 2 countries
- Funders: National Cancer Institute and others
- 1 of 1 finding with company ties
- Humans11
- In silico1
What is colposcopy linked with?
2Studies link colposcopy with 2 measures: CIN2+ detection sensitivity and cervical intraepithelial neoplasia grade 3 or worse.
CIN2+ detection sensitivity
mixedin humans1
1 study
CIN2+ detection sensitivity
mixedin humans1
Colposcopy is associated with CIN2+ detection sensitivity in humans (heterogeneous referral populations) (Approximately 75% pooled sensitivity).
“Pooled colposcopic sensitivity for CIN2+ was approximately 75% in heterogeneous referral populations”
Reviewheterogeneous referral populationscervixfemales
Diagnostics (Basel, Switzerland)
Cervical intraepithelial neoplasia grade 3 or worse
upin humans1
1 study
Cervical intraepithelial neoplasia grade 3 or worse
upin humans1
Colposcopy predicts cervical intraepithelial neoplasia grade 3 or worse in HPV-positive women (91.2% (95% CI 88.9-93.2)).
“Sensitivity was 91·2% (95% CI 88·9-93·2) for CIN3+”
Human trialin HPV-positive womencervixfemalesn = 4,499
The Lancet. Global health
Funding
1 grant since 2022National Cancer Institute$604K